Literature DB >> 23913513

The role of macrophage migration inhibitory factor in autoimmune liver disease.

David N Assis1, Lin Leng, Xin Du, Clarence K Zhang, Gerrit Grieb, Melanie Merk, Alvaro Baeza Garcia, Catherine McCrann, Julius Chapiro, Andreas Meinhardt, Yuka Mizue, David J Nikolic-Paterson, Jürgen Bernhagen, Marshall M Kaplan, Hongyu Zhao, James L Boyer, Richard Bucala.   

Abstract

UNLABELLED: The role of the cytokine, macrophage migration inhibitory factor (MIF), and its receptor, CD74, was assessed in autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC). Two MIF promoter polymorphisms, a functional -794 CATT5-8 microsatellite repeat (rs5844572) and a -173 G/C single-nucleotide polymorphism (rs755622), were analyzed in DNA samples from over 500 patients with AIH, PBC, and controls. We found a higher frequency of the proinflammatory and high-expression -794 CATT7 allele in AIH, compared to PBC, whereas lower frequency was found in PBC, compared to both AIH and healthy controls. MIF and soluble MIF receptor (CD74) were measured by enzyme-linked immunosorbent assay in 165 serum samples of AIH, PBC, and controls. Circulating serum and hepatic MIF expression was elevated in patients with AIH and PBC versus healthy controls. We also identified a truncated circulating form of the MIF receptor, CD74, that is released from hepatic stellate cells and that binds MIF, neutralizing its signal transduction activity. Significantly higher levels of CD74 were found in patients with PBC versus AIH and controls.
CONCLUSIONS: These data suggest a distinct genetic and immunopathogenic basis for AIH and PBC at the MIF locus. Circulating MIF and MIF receptor profiles distinguish PBC from the more inflammatory phenotype of AIH and may play a role in pathogenesis and as biomarkers of these diseases.
© 2013 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23913513      PMCID: PMC3877200          DOI: 10.1002/hep.26664

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  44 in total

1.  A secreted form of the major histocompatibility complex class II-associated invariant chain inhibiting T cell activation.

Authors:  E E Eynon; C Schlax; J Pieters
Journal:  J Biol Chem       Date:  1999-09-10       Impact factor: 5.157

Review 2.  Primary biliary cirrhosis.

Authors:  Marshall M Kaplan; M Eric Gershwin
Journal:  N Engl J Med       Date:  2005-09-22       Impact factor: 91.245

3.  PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data.

Authors:  Janis E Wigginton; Gonçalo R Abecasis
Journal:  Bioinformatics       Date:  2005-06-09       Impact factor: 6.937

4.  The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF).

Authors:  Melanie Merk; Swen Zierow; Lin Leng; Rituparna Das; Xin Du; Wibke Schulte; Juan Fan; Hongqi Lue; Yibang Chen; Huabao Xiong; Frederic Chagnon; Jürgen Bernhagen; Elias Lolis; Gil Mor; Olivier Lesur; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-04       Impact factor: 11.205

5.  Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.

Authors:  Timothy R D J Radstake; Fred C G J Sweep; Paco Welsing; Barbara Franke; Sita H H M Vermeulen; Anneke Geurts-Moespot; Thierry Calandra; Rachelle Donn; Piet L C M van Riel
Journal:  Arthritis Rheum       Date:  2005-10

6.  Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis.

Authors:  M D Strettell; P T Donaldson; L J Thomson; P J Santrach; S B Moore; A J Czaja; R Williams
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

7.  Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74.

Authors:  Daniel Heinrichs; Meike Knauel; Christian Offermanns; Marie-Luise Berres; Andreas Nellen; Lin Leng; Petra Schmitz; Richard Bucala; Christian Trautwein; Christian Weber; Jürgen Bernhagen; Hermann E Wasmuth
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

8.  Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.

Authors:  Antoine Sreih; Rana Ezzeddine; Lin Leng; Avery LaChance; Geraldine Yu; Yuka Mizue; Lakshman Subrahmanyan; Bernardo A Pons-Estel; Anna-Karin Abelson; Iva Gunnarsson; Elisabet Svenungsson; Joshua Cavett; Stuart Glenn; Lin Zhang; Ruth Montgomery; Andras Perl; Jane Salmon; Marta E Alarcón-Riquelme; John B Harley; Richard Bucala
Journal:  Arthritis Rheum       Date:  2011-12

9.  Macrophage migration inhibitory factor expression correlates with inflammatory changes in human chronic hepatitis B infection.

Authors:  Hai-Ying Zhang; Amin A Nanji; John M Luk; Xiao-Ru Huang; Chung-Mau Lo; Yong Xiong Chen; Siu-Tsan Yuen; Hui Y Lan; George K K Lau
Journal:  Liver Int       Date:  2005-06       Impact factor: 5.828

10.  Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies.

Authors:  Xiao-bo Zhong; Lin Leng; Anna Beitin; Rui Chen; Courtney McDonald; Betty Hsiao; Robert D Jenison; Insoo Kang; Sung-Hwan Park; Annette Lee; Peter Gregersen; Philip Thuma; Patricia Bray-Ward; David C Ward; Richard Bucala
Journal:  Nucleic Acids Res       Date:  2005-08-02       Impact factor: 16.971

View more
  48 in total

1.  Macrophage migration inhibitory factor is required for recruitment of scar-associated macrophages during liver fibrosis.

Authors:  Mark A Barnes; Megan R McMullen; Sanjoy Roychowdhury; Nabil Z Madhun; Kathryn Niese; Mitchell A Olman; Abram B Stavitsky; Richard Bucala; Laura E Nagy
Journal:  J Leukoc Biol       Date:  2014-11-14       Impact factor: 4.962

2.  Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis.

Authors:  Antoine G Sreih; Rana Ezzedine; Lin Leng; Juan Fan; Jie Yao; Duncan Reid; Marta Piecychna; Simon Carette; David Cuthbertson; Paul Dellaripa; Gary S Hoffman; Nader A Khalidi; Curry L Koening; Carol A Langford; Alfred Mahr; Carol A McAlear; Kathleen Maksimowicz-Mckinnon; Paul A Monach; Philip Seo; Ulrich Specks; E William St Clair; John H Stone; Steven R Ytterberg; Jeffrey Edberg; Peter A Merkel; Richard Bucala
Journal:  Arthritis Rheumatol       Date:  2018-10-22       Impact factor: 10.995

3.  Macrophage Migration Inhibitory Factor Levels Correlate with Stroke Recurrence in Patients with Ischemic Stroke.

Authors:  Guangjie Wang; Chuanbin Li; Yashou Liu; Lei Xia
Journal:  Neurotox Res       Date:  2018-12-01       Impact factor: 3.911

4.  Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis.

Authors:  Daniel Heinrichs; Marie-Luise Berres; Melanie Coeuru; Meike Knauel; Andreas Nellen; Petra Fischer; Claudia Philippeit; Richard Bucala; Christian Trautwein; Hermann E Wasmuth; Jürgen Bernhagen
Journal:  FASEB J       Date:  2014-08-13       Impact factor: 5.191

5.  Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension.

Authors:  Hilary M DuBrock; Josanna M Rodriguez-Lopez; Barbara L LeVarge; Michael P Curry; Paul A VanderLaan; Zsuzsanna K Zsengeller; Elizabeth Pernicone; Ioana R Preston; Paul B Yu; Ivana Nikolic; Dihua Xu; Ravi I Thadhani; Richard N Channick; S Ananth Karumanchi
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

6.  Modeling of both shared and distinct interactions between MIF and its homologue D-DT with their common receptor CD74.

Authors:  Roberto Meza-Romero; Gil Benedek; Kelley Jordan; Lin Leng; Georgios Pantouris; Elias Lolis; Richard Bucala; Arthur A Vandenbark
Journal:  Cytokine       Date:  2016-08-27       Impact factor: 3.861

Review 7.  MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.

Authors:  Pathricia V Tilstam; Dake Qi; Lin Leng; Lawrence Young; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2017-07       Impact factor: 6.902

8.  A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients.

Authors:  David N Assis; Hiroki Takahashi; Lin Leng; Mikio Zeniya; James L Boyer; Richard Bucala
Journal:  Dig Dis Sci       Date:  2016-10-01       Impact factor: 3.199

9.  CD74-Downregulation of Placental Macrophage-Trophoblastic Interactions in Preeclampsia.

Authors:  Lukasz Przybyl; Nadine Haase; Michaela Golic; Julianna Rugor; Maria Emilia Solano; Petra Clara Arck; Martin Gauster; Berthold Huppertz; Christoph Emontzpohl; Christian Stoppe; Jürgen Bernhagen; Lin Leng; Richard Bucala; Herbert Schulz; Arnd Heuser; M Susanne Weedon-Fekjær; Guro M Johnsen; Dirk Peetz; Friedrich C Luft; Anne Cathrine Staff; Dominik N Müller; Ralf Dechend; Florian Herse
Journal:  Circ Res       Date:  2016-05-19       Impact factor: 17.367

10.  The clinical significance of the MIF homolog d-dopachrome tautomerase (MIF-2) and its circulating receptor (sCD74) in burn.

Authors:  Bong-Sung Kim; Christian Stoppe; Gerrit Grieb; Lin Leng; Maor Sauler; David Assis; David Simons; Arne Hendrick Boecker; Wibke Schulte; Marta Piecychna; Stephan Hager; Jürgen Bernhagen; Norbert Pallua; Richard Bucala
Journal:  Burns       Date:  2016-05-18       Impact factor: 2.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.